CTOs on the Move

Compass Group Canada

www.compass-canada.com

 
Compass Group PLC is a world-leading food and support services company whose history can be traced back over 60 years. As a FTSE 100 listed company we generated an annual revenue of £17.8 billion in the year to 30 September 2015, operate in around 50 countries, employ over 500,000 people and serve over 4 billion meals every year. The company specialises in providing food and a range of support services across the core sectors of Business & Industry, Healthcare & Seniors, Education, Defence, Offshore & Remote, Sports & Leisure and Vending with an established brand portfolio. By combining fresh ideas with ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Johanna Foods, Inc.

Johanna Foods, Inc. is one of the leading companies in the Manufacturing sector.

daring

100% plant-based chicken. Simply made with natural ingredients. Supremely healthy and delicious.

Glendale Senior Dining

Glendale Dining Services is a food service management company serving independent, assisted living, continuing care, skilled nursing, rehabilitation and retirement communities.

Tender

Tender is a company that creates alternative meat products that have the same texture, taste, and consistency as real meat, with a focus on sustainability and affordability.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.